Note: Funding Information: All authors are affiliated with the Platform foR European Preparedness Against (Re-) emerging Epidemics (PREPARE), funded by the European Union Seventh Framework Programme (grant agreement 602525) consortium and are working together on the design and implementation of the Antivirals for influenza-Like Illness? An rCt of Clinical and Cost effectiveness in primary CarE (ALIC4E) trial, which is part of PREPARE.